Neuropathic Pain

KEI Comments on NIH Proposed Exclusive Patent License to St. Louis University for Treatment and Prevention of Neuropathic Pain With P2Y14 Antagonists

Posted on by Claire Cassedy

On December 3, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) regarding the “Prospective Grant of Exclusive Patent License: Treatment and Prevention of Neuropathic… Continue Reading →

2016: Objection to exclusive license to AestasRx Inc.

Posted on by KEI Staff

(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) Susan Ano, Ph.D., NINDS Technology Transfer, 31 Center Drive, Suite 8A52, MSC2540 Bethesda, MD 20892; Telephone: (301) 435-5515; anos@mail.nih.gov Dear Dr. Ano, I am writing to express… Continue Reading →